Loading
SenzaGen AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Bengt Peter Nählstedt, was filed 19 Mar 2026.
SenzaGen AB: what insiders have been doing
Every trade that managers of SenzaGen AB disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. Between 24 October 2025 and 24 October 2026, 1 insider published 1 filing.
The flow runs one way only: 1 insider bought (1 purchase totalling €3,039) and nobody sold on the market. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a purchase of €3,039 from Bengt Peter Nählstedt, disclosed on 19 March 2026. Those buying include 1 chief executive.
Compared with its exchange (1,028 companies, median 9 filings), a count of 1 filing is below the norm. The full history, which starts in 2018, counts 43 purchases against 19 sales.
The last purchase on record was published on 19 March 2026, which is 218 days ago.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
86
Thresholds
n/a
Buy Volume
€265,407
43 ops. · all time
Sell Volume
€655,939
19 ops. · all time
Who traded when
BuySaleBengt Peter Nählstedt5 buys
Paul Yianni4 buys
Fundamental score
Ranked 22,054 of 26,286 companies
27.5
score / 100
Value18
Quality37
FCF yld-8.1%
Earn yld-7.6%
EV/EBITDA·
ROE-11%
Gross mgn65%
Net mgn-20%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 4.70
Analyst consensus
Income statement
RevenueSEK 58M
Gross profitSEK 37.6M65% margin
EBITDA-SEK 8.3M-14% margin
Net income-SEK 11.6M-15.2% margin
Valuation
P/Book1.7x
Beta0.60
Balance sheet & cash
Market capSEK 152.8M
Total debtSEK 18.9M
Free Cash Flow-SEK 12.3M
Debt / Equity19%
Profitability & ownership
ROE-11.1%
ROA-4.8%
% insiders23.6%
% institutions12.2%
Last declaration on 19 March 2026
Declarations86 total
6,889 shares@ SEK 4.7585.3% of flowAktieISIN SE0010219626FI:csv-afe1ed5a6115d0d1db99
Canonical exit: 17 Jun 2026 (T+90)
250,000 shares@ SEK 0.76100.0% of flowTeckningsoptionFI:A003R608-1
5,000 shares@ SEK 5.164.0% of flowAktieISIN SE0010219626FI:csv-f9eb87fd788772ea15bb
Canonical exit: 22 Sept 2025 (T+90)
10,000 shares@ SEK 5.809.5% of flowAktieISIN SE0010219626FI:csv-e32399d9f705d78f866a
Canonical exit: 25 Aug 2025 (T+90)
10,000 shares@ SEK 5.489.0% of flowAktieISIN SE0010219626FI:csv-096ecbcf4206c4e4d152
Canonical exit: 25 Aug 2025 (T+90)
10,000 shares@ SEK 5.79429.5% of flowAktieISIN SE0010219626FI:csv-1359a9829bbaadb73214
Canonical exit: 25 Aug 2025 (T+90)
10,000 shares@ SEK 5.540.033% mcap100.0% of flowAktieISIN SE0010219626FI:A003P059-1
Canonical exit: 25 Aug 2025 (T+90)
6,495 shares@ SEK 6.42666.4% of flowAktieISIN SE0010219626FI:csv-e5a893d91ab33a163c38
Canonical exit: 15 May 2025 (T+90)
8,488 shares@ SEK 6.32768.3% of flowAktieISIN SE0010219626FI:csv-7c9b8856b4a4e1fbab1b
Canonical exit: 15 May 2025 (T+90)
725 shares@ SEK 6.150.7% of flowAktieISIN SE0010219626FI:csv-d43279b21dcf2413d144
Canonical exit: 18 May 2025 (T+90)
100,000 shares@ SEK 1.389.7% of flowTeckningsoptionFI:csv-95a41395811f9bed9435
50,000 shares@ SEK 1.3828.7% of flowTeckningsoptionFI:csv-218a94844bdc8106577c
50,000 shares@ SEK 1.383.3% of flowTeckningsoptionFI:csv-516d1a86f0ff0d7fd995
2,774 shares@ SEK 7.051.4% of flowAktieISIN SE0010219626FI:csv-de551da8f3c16d412980
Canonical exit: 18 Sept 2024 (T+90)
1,000 shares@ SEK 7.850.6% of flowAktieISIN SE0010219626FI:csv-77e76451eec41791755b
Canonical exit: 12 Sept 2024 (T+90)
3,000 shares@ SEK 7.201.5% of flowAktieISIN SE0010219626FI:csv-ad80a3341f4ce38ee755
Canonical exit: 15 Sept 2024 (T+90)
6,126 shares@ SEK 8.383.7% of flowAktieISIN SE0010219626FI:csv-96094205116e41fefc2b
Canonical exit: 11 Sept 2024 (T+90)
10,100 shares@ SEK 6.204.5% of flowAktieISIN SE0010219626FI:csv-aadbae3feb487ccd79a3
Canonical exit: 27 May 2024 (T+90)
4,081 shares@ SEK 7.402.1% of flowAktieISIN SE0010219626FI:csv-623ab94b6c14df2c03e4
Canonical exit: 15 Feb 2024 (T+90)
5,500 shares@ SEK 9.103.4% of flowAktieISIN SE0010219626FI:csv-3faed77fae5d159c4f73
Canonical exit: 23 Nov 2023 (T+90)
40,000 shares@ SEK 2.3031.3% of flowTeckningsoptionFI:csv-00cb14ba0bc8a6409d5f
50,000 shares@ SEK 2.3046.6% of flowTeckningsoptionFI:csv-3b10bbf9d483eef8eabd
50,000 shares@ SEK 2.30100.0% of flowTeckningsoptionFI:csv-c087b4f37fc14c488983
200,000 shares@ SEK 2.3031.6% of flowTeckningsoptionFI:csv-9f15c2b34e841129417e
50,000 shares@ SEK 2.305.4% of flowTeckningsoptionFI:csv-b7960ae40173d3e493e7
25 of 86 declarations
About SenzaGen AB
SenzaGen AB is a company focused on developing safety tests for chemicals and pharmaceuticals. It specializes in innovative solutions to assess the effects of substances on human health.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
